Management of Metastatic Renal Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 1, 2005-01 ,pp. : 105-113

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Lenalidomide has demonstrated antitumour activity in patients with metastatic renal cancer

By  

Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma

By Olencki Thomas   Malhi Sareena   Mekhail Tarek   Dreicer Robert   Elson Paul   Wood Laura   Bukowski Ronald  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

The Anti-proliferative Effects of Recombinant Human Lysozyme on Human Gastric Cancer Cells

By Guo TK   Zhao XH   Xie XD   Chen ZH   Zhou CS   Wei LL   Zhang H  

The Journal of International Medical Research, Vol. 35, Iss. 3, 2007-05 ,pp. : 353-360

Field House Publishing

Access to resources Recommend Favorite

Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study

By Winquist Eric   Knox Jennifer   Ayoub Jean-Pierre   Wood Lori   Wainman Nancy   Reid Gregory   Pearce Laura   Shah Ajit   Eisenhauer Elizabeth  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 159-167

Springer Publishing Company

Access to resources Recommend Favorite